Literature DB >> 3208248

Synthesis and characterization of lyso-GM3 (II3Neu5Ac Lactosyl sphingosine), de-N-acetyl-GM3 (II3NeuNH2 lactosyl Cer), and related compounds.

G A Nores1, N Hanai, S B Levery, H L Eaton, E K Salyan, S Hakomori.   

Abstract

Various GM3 derivatives which are present in A431 cells have different effects on the activity of the EGF receptor kinase. In order to systematically study these effects, the following GM3 derivatives have been synthesized: de-N-acetyl-GM3 (D1), de-N-acetyl-lyso-GM3 (D2), lyso-GM3 (D3), de-N-acetyl-GM3 with N-acetylsphingosine (D4), and GM3 with N-acetylsphingosine (D3). A crucial step for the preparation of D1 is the use of mild alkaline conditions of hydrolysis under which the N-acetyl group of sialic acid is preferentially hydrolyzed. For the preparation of D3, conditions which allowed preferential N-acetylation of the amino group of the neuraminic acid moiety were devised, i.e., D2 was incorporated in a dipalmitoyl-phosphatidylcholine (dpPC) liposome in which the sphingosine moiety was protected and the amino group of neuraminic acid was N-acetylated with acetate and a water-soluble catalyst, 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide (DEC). When an aqueous micellar solution of D2 was treated with acetic anhydride and sodium hydrogencarbonate, N-acetylation occurred at the amino groups of both neuraminosyl and sphingosyl residues, yielding D5. The structures of these derivatives were verified by 1H-n.m.r. spectroscopy and mass spectrometry.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3208248     DOI: 10.1016/0008-6215(88)84135-1

Source DB:  PubMed          Journal:  Carbohydr Res        ISSN: 0008-6215            Impact factor:   2.104


  10 in total

1.  A ganglioside-specific sialyltransferase localizes to axons and non-Golgi structures in neurons.

Authors:  C A Stern; M Tiemeyer
Journal:  J Neurosci       Date:  2001-03-01       Impact factor: 6.167

2.  Multiplex analysis of sphingolipids using amine-reactive tags (iTRAQ).

Authors:  Takuji Nabetani; Asami Makino; Françoise Hullin-Matsuda; Taka-Aki Hirakawa; Shinji Takeoka; Nozomu Okino; Makoto Ito; Toshihide Kobayashi; Yoshio Hirabayashi
Journal:  J Lipid Res       Date:  2011-04-12       Impact factor: 5.922

3.  Involvement of the acyl chain of ceramide in carbohydrate recognition by an anti-glycolipid monoclonal antibody: the case of an anti-melanoma antibody, M2590, to GM3-ganglioside.

Authors:  S Itonori; K Hidari; Y Sanai; M Taniguchi; Y Nagai
Journal:  Glycoconj J       Date:  1989       Impact factor: 2.916

Review 4.  GM3 and cancer.

Authors:  Sen-Itiroh Hakomori; Kazuko Handa
Journal:  Glycoconj J       Date:  2015-01-23       Impact factor: 2.916

5.  Passive transfer of IgG anti-GM1 antibodies impairs peripheral nerve repair.

Authors:  Pablo H Lopez; Gang Zhang; Jiangyang Zhang; Helmar C Lehmann; John W Griffin; Ronald L Schnaar; Kazim A Sheikh
Journal:  J Neurosci       Date:  2010-07-14       Impact factor: 6.167

6.  A novel ganglioside with a free amino group in bovine brain.

Authors:  K I Hidari; F Irie; M Suzuki; K Kon; S Ando; Y Hirabayashi
Journal:  Biochem J       Date:  1993-11-15       Impact factor: 3.857

7.  Effect of a new de-N-acetyl-lysoglycosphingolipid on chemically-induced inflammatory bowel disease: possible mechanism of action.

Authors:  E Tubaro; C Santiangeli; G Cavallo; L Belogi; G Guida; C Croce; A Modesti
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-12       Impact factor: 3.000

8.  Negative-ion fast atom bombardment tandem mass spectrometry for characterization of sulfated unsaturated disaccharides from heparin and heparan sulfate.

Authors:  T Ii; M Kubota; S Okuda; T Hirano; M Ohashi
Journal:  Glycoconj J       Date:  1995-04       Impact factor: 2.916

Review 9.  Exploration of the Sialic Acid World.

Authors:  Roland Schauer; Johannis P Kamerling
Journal:  Adv Carbohydr Chem Biochem       Date:  2018-11-28       Impact factor: 12.200

10.  Individual Restriction Of Fine Specificity Variability In Anti-GM1 IgG Antibodies Associated With Guillain-Barré Syndrome.

Authors:  Ricardo D Lardone; Nobuhiro Yuki; Fernando J Irazoqui; Gustavo A Nores
Journal:  Sci Rep       Date:  2016-01-28       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.